ALTEOGEN

Founded in 2008, Alteogen is a leading bio venture company whose portfolio includes next-generation Bio-better, with improved efficacy in comparison with existing biologics and biosimilars that demonstrate "comparability" to the existing biologics with proprietary platform technology... Alteogen focus on the cutting edge areas of the industry, long-acting bio-betters, proprietary antibody-drug conjugate, Hybrozyme™, and monoclonal antibody biosimilars.

Also known as: ALTEOGEN Inc

Primary location: Daejeon Korea